Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Bobillo

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|October 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcomeAna Muntañola, Pablo Mozas, Santiago Mercadal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Haematologica|August 30, 2023
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomesPaola Ghione, Salma Ahsanuddin, Efrat Luttwak, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Annals of Hematology|October 13, 2021
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab eraJulio Del Río-Garma, Sabela Bobillo, Javier de la Rubia, et al.
Blood Cancer Journal|June 17, 2021
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapseSabela Bobillo, Erel Joffe, David Sermer, et al.
Blood Advances|July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphomaDavid Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Blood|July 31, 2020
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab eraSabela Bobillo, Erel Joffe, Jessica A Lavery, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|October 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcomeAna Muntañola, Pablo Mozas, Santiago Mercadal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.
Haematologica|August 30, 2023
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomesPaola Ghione, Salma Ahsanuddin, Efrat Luttwak, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Annals of Hematology|October 13, 2021
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab eraJulio Del Río-Garma, Sabela Bobillo, Javier de la Rubia, et al.
Blood Cancer Journal|June 17, 2021
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapseSabela Bobillo, Erel Joffe, David Sermer, et al.
Blood Advances|July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphomaDavid Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Blood|July 31, 2020
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab eraSabela Bobillo, Erel Joffe, Jessica A Lavery, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Pageof 4